1681 Institusjonelt eierskap, Kjøpere - Consun Pharmaceutical Group Limited.

Institusjonelt- og fondseierskap - Kjøpere

De største eierne som har åpnet nye posisjoner i Consun Pharmaceutical Group Limited inkluderer AVES - Avantis Emerging Markets Value ETF, REMG - Emerging Markets Equity Active ETF, AVSE - Avantis Responsible Emerging Markets Equity ETF, og HSDEX - Hartford Schroders Diversified Emerging Markets Fund Class SDR .

Denne siden viser endringer i eierstrukturen ved å liste opp institusjoner, fond og større aksjonærer som har økt sine eierandeler eller åpnet nye posisjoner i løpet av den siste rapporteringsperioden. Grønne rader indikerer nye posisjoner. Klikk på lenkeikonet for å se hele transaksjonshistorikken.

Oppgraderfor å låse opp premiumdata.

Fildato	Kilde	Investor	Aksjer	Δ Aksjer (%)	Rapportert verdi ($1000)	Verdi (%)
2025-07-28	NP	AVSE - Avantis Responsible Emerging Markets Equity ETF	28 000		38
2025-07-25	NP	EEMS - iShares MSCI Emerging Markets Small-Cap ETF This fund is a listed as child fund of BlackRock Inc. and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	118 000		159
2025-07-28	NP	AVEM - Avantis Emerging Markets Equity ETF This fund is a listed as child fund of American Century Companies Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	948 000	46,07	1 280	91,90
2025-06-26	NP	FISMX - Fidelity International Small Cap Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	22 500 000	81,47	26 864	114,52
2025-08-27	NP	THRIVENT SERIES FUND INC - Thrivent International Allocation Portfolio Class A	191 000	24,03	276	51,10
2025-08-28	NP	SIEMX - SIT EMERGING MARKETS EQUITY FUND - CLASS F, effective 1-31-2017 (formerly Class A)	293 211	171,49	423	230,47
2025-07-29	NP	GBFFX - GMO Benchmark-Free Fund Class III	399 000	12,08	539	46,99
2025-06-26	NP	Dimensional Emerging Markets Value Fund - Dimensional Emerging Markets Value Fund This fund is a listed as child fund of Dimensional Fund Advisors Lp and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	2 111 000	0,81	2 514	18,70
2025-06-26	NP	Thrivent Core Funds - Thrivent Core Emerging Markets Equity Fund	761 000	14,26	906	34,62
2025-07-29	NP	GMEMX - GMO Emerging Markets Fund Class II	1 461 000	27,49	1 973	67,35
2025-08-18	NP	PACIFIC SELECT FUND - International Small-Cap Portfolio Class I	1 828 000	11,19	2 640	35,40
2025-07-29	NP	GIMFX - GMO Implementation Fund	760 000	16,21	1 026	52,45
2025-08-20	NP	REMG - Emerging Markets Equity Active ETF	35 000		50
2025-06-30	NP	VFSNX - Vanguard FTSE All-World ex-US Small-Cap Index Fund Institutional Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	1 455 000	3,26	1 733	21,54
2025-06-26	NP	HSDEX - Hartford Schroders Diversified Emerging Markets Fund Class SDR	24 000		29
2025-07-28	NP	AVES - Avantis Emerging Markets Value ETF This fund is a listed as child fund of American Century Companies Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	55 000		74
2025-07-28	NP	AVEE - Avantis Emerging Markets Small Cap Equity ETF	23 000	9,52	31	47,62
2025-06-26	NP	FLKSX - Fidelity Low-Priced Stock K6 Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	606 657	2,14	724	20,87
2025-08-28	NP	QCSTRX - Stock Account Class R1	1 518 000	2,85	2 192	25,20

HK:1681 / Consun Pharmaceutical Group Limited - Institusjonelt eierskap - Kjøpere

Institusjonelt- og fondseierskap - Kjøpere

Other Listings

US:CPHGF
DE:C1P	€ 1,60